| RETRACTED: a pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis S Valastyan, F Reinhardt, N Benaich, D Calogrias, AM Szász, ZC Wang, ... Cell 137 (6), 1032-1046, 2009 | 1077 | 2009 |
| Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients AM Szász, A Lánczky, Á Nagy, S Förster, K Hark, JE Green, ... Oncotarget 7 (31), 49322, 2016 | 961 | 2016 |
| A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer Z Mihály, M Kormos, A Lánczky, M Dank, J Budczies, MA Szász, B Győrffy Breast cancer research and treatment 140, 219-232, 2013 | 208 | 2013 |
| Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations D Brown, D Smeets, B Székely, D Larsimont, AM Szász, PY Adnet, ... Nature communications 8 (1), 14944, 2017 | 190 | 2017 |
| Clinical, prognostic, and therapeutic aspects of urachal carcinoma—a comprehensive review with meta-analysis of 1,010 cases T Szarvas, O Módos, C Niedworok, H Reis, A Szendröi, MA Szász, ... Urologic Oncology: Seminars and Original Investigations 34 (9), 388-398, 2016 | 186 | 2016 |
| Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis I Teleki, AM Szasz, ME Maros, B Gyorffy, J Kulka, N Meggyeshazi, ... PloS one 9 (11), e112541, 2014 | 117 | 2014 |
| Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy B Ács, V Zámbó, L Vízkeleti, AM Szász, L Madaras, G Szentmártoni, ... Diagnostic pathology 12, 1-12, 2017 | 112 | 2017 |
| Breast carcinoma subtypes show different patterns of metastatic behavior IA Molnár, BÁ Molnár, L Vízkeleti, K Fekete, J Tamás, P Deák, C Szundi, ... Virchows Archiv 470, 275-283, 2017 | 108 | 2017 |
| Expression of tight junction protein claudin-4 in basal-like breast carcinomas J Kulka, AM Szász, Z Németh, L Madaras, Z Schaff, IA Molnár, AM Tőkés Pathology & Oncology Research 15, 59-64, 2009 | 99 | 2009 |
| Claudin-1,− 2,− 3,− 4,− 7,− 8, and− 10 protein expression in biliary tract cancers Z Németh, AM Szász, P Tátrai, J Németh, H Györffy, Á Somorácz, ... Journal of Histochemistry & Cytochemistry 57 (2), 113-121, 2009 | 90 | 2009 |
| The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer Z Baranyai, M Krzystanek, V Jósa, K Dede, E Ágoston, M Szász, D Sinkó, ... Thrombosis and haemostasis 112 (03), 483-490, 2014 | 86 | 2014 |
| Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis AM Szász, AM Tokes, M Micsinai, T Krenács, C Jakab, L Lukacs, ... Clinical & experimental metastasis 28, 55-63, 2011 | 86 | 2011 |
| Quo vadis oncological hyperthermia (2020)? SY Lee, G Fiorentini, AM Szasz, G Szigeti, A Szasz, CA Minnaar Frontiers in oncology 10, 1690, 2020 | 83 | 2020 |
| Clinicopathological features and prognosis of pregnancy associated breast cancer–a matched case control study L Madaras, KA Kovács, AM Szász, I Kenessey, AM Tőkés, B Székely, ... Pathology & Oncology Research 20, 581-590, 2014 | 77 | 2014 |
| Identification of a claudin‐4 and E‐cadherin score to predict prognosis in breast cancer AM Szasz, Z Nemeth, B Gyorffy, M Micsinai, T Krenacs, Z Baranyai, ... Cancer science 102 (12), 2248-2254, 2011 | 74 | 2011 |
| The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer I Teleki, T Krenacs, MA Szasz, J Kulka, B Wichmann, C Leo, ... BMC cancer 13, 1-13, 2013 | 70 | 2013 |
| Long-term psychological and sexual outcomes of severe penile hypospadias repair A Kiss, B Sulya, AM Szász, I Romics, Z Kelemen, J Tóth, M Merksz, ... The journal of sexual medicine 8 (5), 1529-1539, 2011 | 65 | 2011 |
| Prognostic factors and survival of renal clear cell carcinoma patients with bone metastases A Szendrői, E Dinya, M Kardos, AM Szász, Z Németh, K Áts, J Kiss, I Antal, ... Pathology & Oncology Research 16, 29-38, 2010 | 58 | 2010 |
| AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients G Bottai, C Raschioni, B Székely, L Di Tommaso, AM Szász, A Losurdo, ... NPJ breast cancer 2 (1), 1-10, 2016 | 57 | 2016 |
| Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers N Tung, A Miron, SJ Schnitt, S Gautam, K Fetten, J Kaplan, Y Yassin, ... Breast Cancer Research 12, 1-13, 2010 | 57 | 2010 |
Balázs Győrffy MD PhDClarivate Highly Cited, Semmelweis, PTE, HUN-REN, ELIXIR, Hungarian Academy of SciencesVerifisert e-postadresse på ttk.mta.hu